Moomoo AI 已提取核心信息
Seth Lederman, the Chief Executive Officer of Tonix Pharmaceuticals Holding Corp. (TNXP), was reported to have engaged in a transaction involving the company's stock on February 27, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and total value of shares, were not disclosed in the announcement. As a result, the number of shares Lederman holds after the action remains unknown.
Seth Lederman, the Chief Executive Officer of Tonix Pharmaceuticals Holding Corp. (TNXP), was reported to have engaged in a transaction involving the company's stock on February 27, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and total value of shares, were not disclosed in the announcement. As a result, the number of shares Lederman holds after the action remains unknown.
据报道，Tonix Pharmicals Holding Corp.（TNXP）首席执行官塞思·莱德曼于2024年2月27日参与了一项涉及该公司股票的交易。公告中未披露该交易的具体细节，包括股票数量、股票性质、交易价格和股票总价值。因此，莱德曼在行动后持有的股票数量仍然未知。
据报道，Tonix Pharmicals Holding Corp.（TNXP）首席执行官塞思·莱德曼于2024年2月27日参与了一项涉及该公司股票的交易。公告中未披露该交易的具体细节，包括股票数量、股票性质、交易价格和股票总价值。因此，莱德曼在行动后持有的股票数量仍然未知。
有用
没用